<link rel="stylesheet" href="styles.f3b1fba60ec7970c.css">

Cumulative Antifibrotic Effect of Rapamycin and Zoledronic Acid in Murine Biliary Fibrosis

dc.contributor.authorAslam, Misbah, Jr.
dc.contributor.authorKhan, Muhammad Ashfaq, Jr.
dc.contributor.authorQureshi, Muhammad Asif
dc.contributor.authorSenkowski, Marcel Sacha, Jr.
dc.contributor.authorNick, Mirko
dc.contributor.authorKaps, Leonard
dc.contributor.authorKim, Yong Ook
dc.contributor.authorSchuppan, Detlef
dc.date.accessioned2026-11-05T11:02:07Z
dc.date.issued2018
dc.description.pages1139A-1140A
dc.description.volume68
dc.identifier.issn0270-9139
dc.identifier.issn1527-3350
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/10859
dc.identifier.wosWOS:000446020503228
dc.language.isoen
dc.publisherWILEY
dc.relation.conferenceAnnual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting
dc.relation.ispartofHEPATOLOGY
dc.subjectGastroenterology & Hepatology
dc.titleCumulative Antifibrotic Effect of Rapamycin and Zoledronic Acid in Murine Biliary Fibrosis
dc.typeMeeting Abstract
oaire.citation.editionScience Citation Index Expanded (SCI-EXPANDED)
oaire.citation.editionConference Proceedings Citation Index - Science (CPCI-S)
oaire.citation.endPage1140A
oaire.citation.startPage1139A
oaire.citation.volume68
person.identifier.ridAER-9743-2022

Files

Collections